Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.

David W DodickAnand S ShewaleRichard B LiptonSeth J BaumSteven C MarcusStephen D SilbersteinJelena M PavlovicNathan L BennettWilliam B YoungHema N ViswanathanJalpa A DoshiHoward Weintraub

Published in: Journal of primary care & community health (2021)

Analyses of more than 230,000 people with migraine showed that ≥20% of commercially insured US migraine patients have a CV condition that specifically contraindicates triptan treatment, and an additional 25% have ≥2 CV risk factors identified as warnings and precautions to triptans.

Keyphrases

cardiovascular disease
risk factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
type diabetes
prognostic factors
electronic health record
machine learning
artificial intelligence
cardiovascular risk factors
data analysis
smoking cessation